TurmiPure Gold® (Bioavailable Turmeric — Naturex)

Curcuma longa
Evidence Level
Limited
1 Clinical Trial
5 Documented Benefits
2/5 Evidence Score

TurmiPure Gold is a turmeric extract developed by Naturex (now part of Givaudan) and formulated for higher curcuminoid absorption. In the company's open-label pharmacokinetic study, a 300 mg dose delivered roughly 20 times more curcuminoids per milligram than a standard extract, but at real serving sizes the blood-level advantage was modest and a micellar product delivered more. The one human efficacy trial tested 5-day exercise recovery; its primary muscle-soreness outcome was not significant, with benefits confined to secondary measures, mostly in men.

Studied Dose 300 mg/day (about 90 mg curcuminoids) for 5 days in the muscle-recovery trial; 1000 mg/day for 5 weeks in the tolerance study.
Active Compound Curcuminoids in proprietary bioavailability-enhanced formulation

Benefits

Higher Curcuminoid Absorption Per Milligram

In an open-label crossover study, TurmiPure Gold's curcuminoid absorption per milligram was about 20 times that of a standard extract. At the actual doses tested the total blood-level difference was small, and a micellar formulation absorbed more. Bioavailability is a formulation property, not a proven health benefit.

Exercise-Induced Muscle Soreness Recovery

In one 5-day trial in moderately active adults, the primary muscle-soreness endpoint after downhill running was no different from placebo. Some secondary measures (soreness recovery, torque loss, jump power) were better than placebo, mostly in men. No inflammatory markers were measured.

No Joint or Arthritis Trial for This Product

General turmeric research is often cited for joints, but TurmiPure Gold itself has not been tested for joint pain, stiffness, or arthritis in people. 'Delivers more active to joint tissues' has not been measured.

Healthy Aging

No study has tested TurmiPure Gold for any aging-related outcome in people; this rests on general curcumin literature, not this formulation.

Naturex/Givaudan Quality

Premium ingredient quality from established global botanical supplier.

Mechanism of action

1

Bioavailability Enhancement

Naturex's proprietary technology enhances curcumin absorption — addresses turmeric's primary clinical limitation.

2

NF-kB and COX-2 Inhibition

Same fundamental anti-inflammatory mechanism as other curcumin; bioavailability delivers more active.

3

Antioxidant Activity

Direct antioxidant + NRF2 pathway activation.

Clinical trials

1
TurmiPure Gold Pharmacokinetic (Absorption) Study, Not an Efficacy Trial
PubMed

Open-label randomized crossover pharmacokinetic study in 30 healthy adults comparing single-dose curcuminoid absorption of TurmiPure Gold and four other turmeric formulations. Industry-funded (Naturex/Givaudan).

Healthy adults.

Per milligram, curcuminoid absorption was about 20 times that of a standard extract; at the doses actually used the total blood-level difference was modest, and a micellar formulation absorbed more.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress.
Yellow staining (mouth, urine) — harmless.
Allergic reactions rare.
Theoretical bleeding at high doses. Curcumin has a documented and growing signal of liver injury (hepatotoxicity), and enhanced-absorption formulations that raise systemic curcuminoid exposure are specifically implicated; regulators in several countries have issued cautions.

Important Drug interactions

Anticoagulants — modest antiplatelet effects.
Diabetes medications — modest hypoglycemic effects.
Pre-surgery — discontinue 1-2 weeks before.
Gallstones — curcumin cholagogue; avoid.
Pregnancy — culinary turmeric safe; concentrated supplementation limited safety data; avoid high-dose.
Hepatically-metabolized medications — modest CYP interactions.

Frequently asked questions about TurmiPure Gold® (Bioavailable Turmeric — Naturex)

What is TurmiPure Gold?

TurmiPure Gold is a turmeric extract developed by Naturex (now part of Givaudan) and formulated for higher curcuminoid absorption. In the company's open-label pharmacokinetic study, a 300 mg dose delivered roughly 20 times more curcuminoids per milligram than a standard extract, but at real serving sizes the blood-leve…

What is TurmiPure Gold used for?

TurmiPure Gold is researched primarily for Muscle & Recovery. In an open-label crossover study, TurmiPure Gold's curcuminoid absorption per milligram was about 20 times that of a standard extract.

What is the recommended dosage of TurmiPure Gold?

The clinically studied dose is 300 mg/day (about 90 mg curcuminoids) for 5 days in the muscle-recovery trial; 1000 mg/day for 5 weeks in the tolerance study. Always follow the product label and check with a healthcare provider for personal advice.

Is TurmiPure Gold safe, and does it have side effects?

For most healthy adults, TurmiPure Gold is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. Mild GI distress. It may also interact with some medications. TurmiPure Gold is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does TurmiPure Gold interact with any medications?

Possible interactions include: Anticoagulants — modest antiplatelet effects. Diabetes medications — modest hypoglycemic effects. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for TurmiPure Gold?

NutraSmarts rates the evidence for TurmiPure Gold as Limited (2 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Fanca-Berthon P, Tenon M, Bouter-Banon SL, Manfre A, Maudet C, Dion A, et al. Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study. J Nutr. 2021;151(7):1802-1816. doi: 10.1093/jn/nxab087.PubMedUsed to support: Open-label randomized crossover pharmacokinetic study in 30 healthy adults. Per milligram, a 300 mg dose of TurmiPure Gold gave far higher curcuminoid absorption than a 1500 mg standard extract (dose-normalized total-curcuminoid AUC about 73 versus 4). At the actual doses used, its total curcuminoid AUC (6520) was only modestly above the standard extract (5080), and a micellar formulation delivered more (8540). This is an absorption measurement, not a health outcome. Industry-funded, authored by Naturex/Givaudan staff.
  2. Schonenberger KA, Laval J, Woods T, Truillet R, Naranjo-Modad S, Mettler S, et al. A randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults. J Int Soc Sports Nutr. 2025;22(1):2568048. doi: 10.1080/15502783.2025.2568048.PubMedUsed to support: Double-blind, placebo-controlled crossover RCT in 44 moderately active adults (34 men, 10 women), 300 mg/day (90 mg curcuminoids) for 5 days, with muscle damage induced by a downhill run. The primary endpoint, muscle-soreness area under the curve to 72 hours, was not significantly different from placebo (only a non-significant 72h trend, p=0.0776). Some secondary measures (soreness recovery, isokinetic torque loss, vertical-jump power) were significantly better than placebo, mostly in the male primary population. Single small trial, industry-funded (Givaudan employees).
  3. Laval J, Phipps KR, Brinet S, Fournier MC, Douillard B, Pham S, et al. Safety assessment and gastrointestinal tolerance of a novel highly bioavailable turmeric extract formulation: A randomised, double-blind, placebo controlled clinical trial. Toxicol Rep. 2026;16:102176. doi: 10.1016/j.toxrep.2025.102176.PubMedUsed to support: Double-blind, placebo-controlled RCT in 60 healthy adults taking 1000 mg/day for 5 weeks (above the 300 mg recommended serving). Gastrointestinal tolerance, blood chemistry, urinalysis, and adverse events did not differ significantly from placebo. This is a tolerability and safety study, not an efficacy study. Industry-funded, authored by Givaudan-affiliated staff.